Patent: 9,585,884
✉ Email this page to a colleague
Summary for Patent: 9,585,884
Title: | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 |
Abstract: | The present invention relates to new pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof. ##STR00001## |
Inventor(s): | Rao; Tadimeti (San Diego, CA), Zhang; Chengzhi (San Diego, CA) |
Assignee: | Auspex Pharmaceuticals, Inc. (La Jolla, CA) |
Application Number: | 14/107,953 |
Patent Claims: | see list of patent claims |
Details for Patent 9,585,884
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bausch Health Us, Llc | IPRIVASK | desirudin | For Injection | 021271 | 04/04/2003 | ⤷ Try a Trial | 2029-07-28 |
Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2029-07-28 |
Genentech, Inc. | ACTIVASE | alteplase | For Injection | 103172 | 11/13/1987 | ⤷ Try a Trial | 2029-07-28 |
Genentech, Inc. | CATHFLO ACTIVASE | alteplase | For Injection | 103172 | 09/04/2001 | ⤷ Try a Trial | 2029-07-28 |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 12/22/1994 | ⤷ Try a Trial | 2029-07-28 |
Chiesi Usa, Inc. | RETAVASE | reteplase | For Injection | 103786 | 10/30/1996 | ⤷ Try a Trial | 2029-07-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |